Literature DB >> 698034

A procedure for monitoring cyclophosphamide and isophosphamide in biological samples.

B Whiting, S H Miller, B Caddy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 698034      PMCID： PMC1429478          DOI： 10.1111/j.1365-2125.1978.tb00869.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography.

Authors:  C Pantarotto; A Martini; G Belvedere; M G Donelli; A Frigerio
Journal:  Cancer Treat Rep       Date:  1976-04

2.  Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens.

Authors:  C Pantarotto; A Bossi; G Belvedere; A Martini; M G Donelli; A Frigerio
Journal:  J Pharm Sci       Date:  1974-10       Impact factor: 3.534

3.  Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites.

Authors:  I Jardine; R Brundrett; M Colvin; C Fenselau
Journal:  Cancer Treat Rep       Date:  1976-04
  3 in total
  3 in total

Review 1.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  L B Grochow; M Colvin
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

2.  British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

3.  In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

Authors:  A P Wilson; F E Neal
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.